Toplak, Hermann

European Guidelines for Obesity Management in Adults

Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts

Obesity, Physical Activity, DietPharmacology and Obesity Treatment

Cited by 3,432

Definition and diagnostic criteria of clinical obesity

Rubino, F., Cummings, D. E., Eckel, R. H., Cohen, R. V., Wilding, J. P. H., Brown, W. A., Stanford, F. C., Batterham, R. L., Farooqi, I. S., Farpour-Lambert, N. J., et al. (2025) · The Lancet Diabetes & Endocrinology

Obesity and Health PracticesObesity, Physical Activity, Diet

Cited by 1,811

European Practical and Patient-Centred Guidelines for Adult Obesity Management in Primary Care

Durrer Schutz, D., Busetto, L., Dicker, D., Farpour-Lambert, N., Pryke, R., Toplak, H., Widmer, D., Yumuk, V., & Schutz, Y. (2019) · Obesity Facts

Obesity and Health PracticesObesity, Physical Activity, Diet

Cited by 492

Obesity and type 2 diabetes: Two diseases with a need for combined treatment strategies - EASO can lead the way

Leitner, D. R., Frühbeck, G., Yumuk, V., Schindler, K., Micic, D., Woodward, E., & Toplak, H. (2017) · Obesity Facts

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 431

The ABCD of Obesity: An EASO Position Statement on a Diagnostic Term with Clinical and Scientific Implications

Frühbeck, G., Busetto, L., Dicker, D., Yumuk, V., Goossens, G. H., Hebebrand, J., Halford, J. G. C., Farpour-Lambert, N. J., Blaak, E. E., Woodward, E., et al. (2019) · Obesity Facts

Obesity and Health PracticesObesity, Physical Activity, Diet

Cited by 311

Prevalence, Pathophysiology, Health Consequences and Treatment Options of Obesity in the Elderly: A Guideline

Mathus-Vliegen, E. M. H., Basdevant, A., Finer, N., Hainer, V., Hauner, H., Micic, D., Maislos, M., Roman, G., Schutz, Y., Tsigos, C., et al. (2012) · Obesity Facts

Nutrition and Health in AgingObesity, Physical Activity, Diet

Cited by 261

Sarcopenic obesity: time to meet the challenge

Barazzoni, R., Bischoff, S. C., Boirie, Y., Busetto, L., Cederholm, T., Dicker, D., Toplak, H., Van Gossum, A., Yumuk, V., & Vettor, R. (2018) · Clinical Nutrition

Nutrition and Health in AgingMuscle Physiology and Disorders

Cited by 260

Sarcopenic obesity: time to meet the challenge

Barazzoni, R., Bischoff, S., Boirie, Y., Busetto, L., Cederholm, T., Dicker, D., Toplak, H., Van Gossum, A., Yumuk, V., & Vettor, R. (2018) · Obesity Facts

Nutrition and Health in AgingMuscle Physiology and Disorders

Cited by 244

Treatment Modalities of Obesity

Hainer, V., Toplak, H., & Mitrakou, A. (2008) · Diabetes Care

Bariatric Surgery and OutcomesPharmacology and Obesity Treatment

Cited by 231

Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended release

Garvey, W. T., Ryan, D. H., Henry, R., Bohannon, N. J. V., Toplak, H., Schwiers, M., Troupin, B., & Day, W. W. (2014) · Diabetes Care

Pharmacology and Obesity TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 215

European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity

Pasquali, R., Casanueva, F., Haluzik, M., van Hulsteijn, L., Ledoux, S., Monteiro, M. P., Salvador, J., Santini, F., Toplak, H., & Dekkers, O. M. (2020) · European Journal of Endocrinology

Thyroid Disorders and TreatmentsAdipokines, Inflammation, and Metabolic Diseases

Cited by 188

Prevalence of endocrine disorders in obese patients: systematic review and meta-analysis

van Hulsteijn, L. T., Pasquali, R., Casanueva, F., Haluzik, M., Ledoux, S., Monteiro, M. P., Salvador, J., Santini, F., Toplak, H., & Dekkers, O. M. (2020) · European Journal of Endocrinology

Thyroid Disorders and TreatmentsHormonal and reproductive studies

Cited by 103

Effects of low‐dose l‐arginine on insulin‐mediated vasodilatation and insulin sensitivity

WASCHER, T. C., GRAIER, W. F., DITTRICH, P., HUSSAIN, M. A., BAHADORI, B., WALLNER, S., & TOPLAK, H. (1997) · European Journal of Clinical Investigation

Nitric Oxide and Endothelin EffectsDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 87

The Effect of Semaglutide on Mortality and COVID-19–Related Deaths

Scirica, B. M., Lincoff, A. M., Lingvay, I., Bogdanski, P., Buscemi, S., Colhoun, H., Craciun, A.-E., Ezhov, M., Hardt-Lindberg, S., Kleist Jeppesen, O., et al. (2024) · Journal of the American College of Cardiology

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 51

A pilot study of mobile phone-based therapy for obese patients

Morak, J., Schindler, K., Goerzer, E., Kastner, P., Toplak, H., Ludvik, B., & Schreier, G. (2008) · Journal of Telemedicine and Telecare

Mobile Health and mHealth ApplicationsTelemedicine and Telehealth Implementation

Cited by 40

Interrelated aldosterone and parathyroid hormone mutually modify cardiovascular mortality risk

Tomaschitz, A., Pilz, S., Rus-Machan, J., Meinitzer, A., Brandenburg, V. M., Scharnagl, H., Kapl, M., Grammer, T., Ritz, E., Horina, J. H., et al. (2015) · International Journal of Cardiology

Hormonal Regulation and HypertensionParathyroid Disorders and Treatments

Cited by 27

Chondrodysplasia punctata with a mild clinical course

Nuoffer, J. M., Pfammatter, J. P., Spahr, A., Toplak, H., Wanders, R. J. A., Schutgens, R. B. H., & Wiesmann, U. N. (1994) · Journal of Inherited Metabolic Disease

Metabolism and Genetic DisordersLysosomal Storage Disorders Research

Cited by 20

Early and Strong Leptin Reduction Is Predictive for Long-Term Weight Loss during High-Protein, Low-Glycaemic Meal Replacement—A Subanalysis of the Randomised-Controlled ACOORH Trial

Kempf, K., Röhling, M., Banzer, W., Braumann, K. M., Halle, M., Schaller, N., McCarthy, D., Predel, H. G., Schenkenberger, I., Tan, S., et al. (2022) · Nutrients

Regulation of Appetite and ObesityAdipokines, Inflammation, and Metabolic Diseases

Cited by 14